Greater Cannabis Company (GCAN) Return on Sales (2017 - 2021)

Greater Cannabis Company's Return on Sales history runs 5 years deep, the most recent figure standing at 0.48% for Q4 2021.

• On a quarterly basis, Return on Sales fell 30.0% year-over-year to 0.48% in Q4 2021; TTM through Dec 2021 was 0.48%, a 30.0% decrease from a year earlier, with the FY2021 full-year figure at 0.48%, down 28.0% from the prior year.
• Return on Sales rose to 0.48% in Q4 2021 per GCAN's latest filing, from 0.62% in the prior quarter.
• Across five years, Return on Sales topped out at 0.23% in Q2 2020 and bottomed at 4.51% in Q2 2017.
• The 5-year median for Return on Sales is 0.24% (2020), against an average of 0.84%.
• Across the five-year window, Return on Sales jumped 452 bps in 2018 and slumped 244 bps in 2019, its largest moves.
• Year by year, Return on Sales stood at 2.83% in 2017, then soared by 100 bps to 0.0% in 2018, then slumped by 86584 bps to 2.44% in 2019, then surged by 93 bps to 0.18% in 2020, then plunged by 163 bps to 0.48% in 2021.
• Per Business Quant, the three latest GCAN Return on Sales figures stand at 0.48% (Q4 2021), 0.62% (Q3 2021), and 0.03% (Q2 2021).